See What HealthDay Can Do For You
Contact Us

Risk-Adjusted Readmission Rates Similar After Colorectal Sx

Little variation in hospital readmission rates after adjustment for patient characteristics, comorbidities

Risk-Adjusted Readmission Rates Similar After Colorectal Sx

FRIDAY, Oct. 24, 2014 (HealthDay News) -- There is little variation in risk-adjusted hospital readmission rates after colorectal surgery, according to a study published online Oct. 22 in JAMA Surgery.

Donald J. Lucas, M.D., M.P.H., from the Walter Reed National Military Medical Center in Bethesda, Md., and colleagues examined the variability in risk-adjusted readmission rates after colorectal surgery. Observational data were collected from the Surveillance, Epidemiology, and End Results-Medicare linked database for 44,822 patients who underwent colorectal resection for cancer at 1,401 U.S. hospitals.

The researchers found that the 30-day readmission rate was 12.3 percent overall. There was marked variation in raw readmission rates among hospitals that performed at least five operations annually, with a range of 0 to 41.2 percent. No significant variability was found in readmission rates among hospitals after adjustment for patient characteristics, comorbidities, and operation types, with a range of 11.3 to 13.2 percent. At every hospital, the 95 percent confidence interval for hospital-specific readmission overlapped the overall mean.

"The use of readmission rates as a high-stakes quality measure for payment adjustment or public reporting across surgical specialties should proceed cautiously and must include appropriate risk adjustment," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.